nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Estrone—prostate cancer	0.327	0.569	CrCtD
Levorphanol—Estradiol—prostate cancer	0.248	0.431	CrCtD
Levorphanol—Dezocine—Estrone—prostate cancer	0.0455	0.129	CrCrCtD
Levorphanol—Estrone—Estradiol valerate/Dienogest—prostate cancer	0.0386	0.109	CrCrCtD
Levorphanol—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.0386	0.109	CrCrCtD
Levorphanol—Dezocine—Estradiol—prostate cancer	0.0344	0.0975	CrCrCtD
Levorphanol—Estradiol—Estramustine—prostate cancer	0.0329	0.093	CrCrCtD
Levorphanol—Estrone—Estramustine—prostate cancer	0.0329	0.093	CrCrCtD
Levorphanol—Estradiol—Estrone—prostate cancer	0.0261	0.0739	CrCrCtD
Levorphanol—Estradiol—Conjugated Estrogens—prostate cancer	0.023	0.065	CrCrCtD
Levorphanol—Estrone—Conjugated Estrogens—prostate cancer	0.023	0.065	CrCrCtD
Levorphanol—Estrone—Estradiol—prostate cancer	0.0198	0.056	CrCrCtD
Levorphanol—Estrone—Ethinyl Estradiol—prostate cancer	0.0193	0.0546	CrCrCtD
Levorphanol—Estradiol—Ethinyl Estradiol—prostate cancer	0.0193	0.0546	CrCrCtD
Levorphanol—Dextromethorphan—PGRMC1—prostate cancer	0.000492	0.206	CrCbGaD
Levorphanol—Morphine—UGT2B15—prostate cancer	0.000355	0.149	CrCbGaD
Levorphanol—Estradiol—AOX1—prostate cancer	0.00016	0.067	CrCbGaD
Levorphanol—Muscle spasms—Estradiol—prostate cancer	9.69e-05	0.00174	CcSEcCtD
Levorphanol—Arrhythmia—Mitoxantrone—prostate cancer	9.64e-05	0.00173	CcSEcCtD
Levorphanol—Hypotension—Conjugated Estrogens—prostate cancer	9.6e-05	0.00173	CcSEcCtD
Levorphanol—Lethargy—Prednisone—prostate cancer	9.49e-05	0.00171	CcSEcCtD
Levorphanol—Vomiting—Bicalutamide—prostate cancer	9.48e-05	0.00171	CcSEcCtD
Levorphanol—Rash—Bicalutamide—prostate cancer	9.4e-05	0.00169	CcSEcCtD
Levorphanol—Dermatitis—Bicalutamide—prostate cancer	9.4e-05	0.00169	CcSEcCtD
Levorphanol—Insomnia—Goserelin—prostate cancer	9.38e-05	0.00169	CcSEcCtD
Levorphanol—Insomnia—Conjugated Estrogens—prostate cancer	9.29e-05	0.00167	CcSEcCtD
Levorphanol—Agitation—Estradiol—prostate cancer	9.26e-05	0.00167	CcSEcCtD
Levorphanol—Injection site reaction—Doxorubicin—prostate cancer	9.21e-05	0.00166	CcSEcCtD
Levorphanol—Abnormal dreams—Doxorubicin—prostate cancer	9.16e-05	0.00165	CcSEcCtD
Levorphanol—Coma—Epirubicin—prostate cancer	9.15e-05	0.00165	CcSEcCtD
Levorphanol—Affect lability—Prednisone—prostate cancer	9.15e-05	0.00165	CcSEcCtD
Levorphanol—Dyspepsia—Goserelin—prostate cancer	9.13e-05	0.00164	CcSEcCtD
Levorphanol—Dyspepsia—Conjugated Estrogens—prostate cancer	9.05e-05	0.00163	CcSEcCtD
Levorphanol—Pruritus—Ethinyl Estradiol—prostate cancer	8.92e-05	0.0016	CcSEcCtD
Levorphanol—Palpitations—Estradiol—prostate cancer	8.91e-05	0.0016	CcSEcCtD
Levorphanol—Constipation—Goserelin—prostate cancer	8.87e-05	0.0016	CcSEcCtD
Levorphanol—Nausea—Bicalutamide—prostate cancer	8.86e-05	0.00159	CcSEcCtD
Levorphanol—Cardiac arrest—Prednisone—prostate cancer	8.84e-05	0.00159	CcSEcCtD
Levorphanol—Mood swings—Prednisone—prostate cancer	8.81e-05	0.00158	CcSEcCtD
Levorphanol—Constipation—Conjugated Estrogens—prostate cancer	8.79e-05	0.00158	CcSEcCtD
Levorphanol—Abnormal vision—Epirubicin—prostate cancer	8.73e-05	0.00157	CcSEcCtD
Levorphanol—Mental disability—Epirubicin—prostate cancer	8.69e-05	0.00156	CcSEcCtD
Levorphanol—Estrone—ESR2—prostate cancer	8.57e-05	0.0359	CrCbGaD
Levorphanol—Feeling abnormal—Goserelin—prostate cancer	8.55e-05	0.00154	CcSEcCtD
Levorphanol—Gastrointestinal pain—Goserelin—prostate cancer	8.48e-05	0.00153	CcSEcCtD
Levorphanol—Coma—Doxorubicin—prostate cancer	8.47e-05	0.00152	CcSEcCtD
Levorphanol—Dysuria—Capecitabine—prostate cancer	8.43e-05	0.00152	CcSEcCtD
Levorphanol—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	8.4e-05	0.00151	CcSEcCtD
Levorphanol—Dry mouth—Estradiol—prostate cancer	8.39e-05	0.00151	CcSEcCtD
Levorphanol—Dizziness—Ethinyl Estradiol—prostate cancer	8.34e-05	0.0015	CcSEcCtD
Levorphanol—Flushing—Etoposide—prostate cancer	8.33e-05	0.0015	CcSEcCtD
Levorphanol—Confusional state—Estradiol—prostate cancer	8.29e-05	0.00149	CcSEcCtD
Levorphanol—Urticaria—Goserelin—prostate cancer	8.24e-05	0.00148	CcSEcCtD
Levorphanol—Abdominal pain—Goserelin—prostate cancer	8.2e-05	0.00148	CcSEcCtD
Levorphanol—Renal failure—Docetaxel—prostate cancer	8.17e-05	0.00147	CcSEcCtD
Levorphanol—Urticaria—Conjugated Estrogens—prostate cancer	8.16e-05	0.00147	CcSEcCtD
Levorphanol—Estradiol—SLC22A3—prostate cancer	8.15e-05	0.0341	CrCbGaD
Levorphanol—Convulsion—Mitoxantrone—prostate cancer	8.14e-05	0.00146	CcSEcCtD
Levorphanol—Abdominal pain—Conjugated Estrogens—prostate cancer	8.12e-05	0.00146	CcSEcCtD
Levorphanol—Shock—Estradiol—prostate cancer	8.09e-05	0.00146	CcSEcCtD
Levorphanol—Abnormal vision—Doxorubicin—prostate cancer	8.08e-05	0.00145	CcSEcCtD
Levorphanol—Mental disability—Doxorubicin—prostate cancer	8.04e-05	0.00145	CcSEcCtD
Levorphanol—Tachycardia—Estradiol—prostate cancer	8.03e-05	0.00144	CcSEcCtD
Levorphanol—Vomiting—Ethinyl Estradiol—prostate cancer	8.02e-05	0.00144	CcSEcCtD
Levorphanol—Hyperhidrosis—Estradiol—prostate cancer	7.95e-05	0.00143	CcSEcCtD
Levorphanol—Rash—Ethinyl Estradiol—prostate cancer	7.95e-05	0.00143	CcSEcCtD
Levorphanol—Dermatitis—Ethinyl Estradiol—prostate cancer	7.94e-05	0.00143	CcSEcCtD
Levorphanol—Renal failure—Capecitabine—prostate cancer	7.91e-05	0.00142	CcSEcCtD
Levorphanol—Estrone—SHBG—prostate cancer	7.81e-05	0.0327	CrCbGaD
Levorphanol—Estrone—CYP1B1—prostate cancer	7.81e-05	0.0327	CrCbGaD
Levorphanol—Confusional state—Mitoxantrone—prostate cancer	7.73e-05	0.00139	CcSEcCtD
Levorphanol—Shock—Mitoxantrone—prostate cancer	7.54e-05	0.00136	CcSEcCtD
Levorphanol—Muscle spasms—Etoposide—prostate cancer	7.51e-05	0.00135	CcSEcCtD
Levorphanol—Nausea—Ethinyl Estradiol—prostate cancer	7.49e-05	0.00135	CcSEcCtD
Levorphanol—Tachycardia—Mitoxantrone—prostate cancer	7.48e-05	0.00135	CcSEcCtD
Levorphanol—Insomnia—Estradiol—prostate cancer	7.44e-05	0.00134	CcSEcCtD
Levorphanol—Lethargy—Epirubicin—prostate cancer	7.42e-05	0.00133	CcSEcCtD
Levorphanol—Hyperhidrosis—Mitoxantrone—prostate cancer	7.41e-05	0.00133	CcSEcCtD
Levorphanol—Bradycardia—Capecitabine—prostate cancer	7.35e-05	0.00132	CcSEcCtD
Levorphanol—Pruritus—Goserelin—prostate cancer	7.34e-05	0.00132	CcSEcCtD
Levorphanol—Pruritus—Conjugated Estrogens—prostate cancer	7.27e-05	0.00131	CcSEcCtD
Levorphanol—Diplopia—Epirubicin—prostate cancer	7.27e-05	0.00131	CcSEcCtD
Levorphanol—Dyspepsia—Estradiol—prostate cancer	7.24e-05	0.0013	CcSEcCtD
Levorphanol—Visual impairment—Docetaxel—prostate cancer	7.19e-05	0.00129	CcSEcCtD
Levorphanol—Hypotension—Mitoxantrone—prostate cancer	7.16e-05	0.00129	CcSEcCtD
Levorphanol—Affect lability—Epirubicin—prostate cancer	7.16e-05	0.00129	CcSEcCtD
Levorphanol—Constipation—Estradiol—prostate cancer	7.03e-05	0.00127	CcSEcCtD
Levorphanol—Visual impairment—Capecitabine—prostate cancer	6.96e-05	0.00125	CcSEcCtD
Levorphanol—Flushing—Docetaxel—prostate cancer	6.92e-05	0.00125	CcSEcCtD
Levorphanol—Cardiac arrest—Epirubicin—prostate cancer	6.91e-05	0.00124	CcSEcCtD
Levorphanol—Mood swings—Epirubicin—prostate cancer	6.89e-05	0.00124	CcSEcCtD
Levorphanol—Lethargy—Doxorubicin—prostate cancer	6.86e-05	0.00124	CcSEcCtD
Levorphanol—Dizziness—Goserelin—prostate cancer	6.86e-05	0.00123	CcSEcCtD
Levorphanol—Dizziness—Conjugated Estrogens—prostate cancer	6.8e-05	0.00122	CcSEcCtD
Levorphanol—Feeling abnormal—Estradiol—prostate cancer	6.78e-05	0.00122	CcSEcCtD
Levorphanol—Convulsion—Etoposide—prostate cancer	6.77e-05	0.00122	CcSEcCtD
Levorphanol—Dyspepsia—Mitoxantrone—prostate cancer	6.75e-05	0.00121	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—prostate cancer	6.73e-05	0.00121	CcSEcCtD
Levorphanol—Gastrointestinal pain—Estradiol—prostate cancer	6.73e-05	0.00121	CcSEcCtD
Levorphanol—Flushing—Capecitabine—prostate cancer	6.7e-05	0.00121	CcSEcCtD
Levorphanol—Arrhythmia—Docetaxel—prostate cancer	6.66e-05	0.0012	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—prostate cancer	6.62e-05	0.00119	CcSEcCtD
Levorphanol—Vomiting—Goserelin—prostate cancer	6.6e-05	0.00119	CcSEcCtD
Levorphanol—Constipation—Mitoxantrone—prostate cancer	6.55e-05	0.00118	CcSEcCtD
Levorphanol—Bradycardia—Prednisone—prostate cancer	6.55e-05	0.00118	CcSEcCtD
Levorphanol—Rash—Goserelin—prostate cancer	6.54e-05	0.00118	CcSEcCtD
Levorphanol—Dermatitis—Goserelin—prostate cancer	6.54e-05	0.00118	CcSEcCtD
Levorphanol—Vomiting—Conjugated Estrogens—prostate cancer	6.53e-05	0.00118	CcSEcCtD
Levorphanol—Urticaria—Estradiol—prostate cancer	6.53e-05	0.00118	CcSEcCtD
Levorphanol—Abdominal pain—Estradiol—prostate cancer	6.5e-05	0.00117	CcSEcCtD
Levorphanol—Estradiol—ESR2—prostate cancer	6.49e-05	0.0272	CrCbGaD
Levorphanol—Dextromethorphan—CYP3A5—prostate cancer	6.48e-05	0.0272	CrCbGaD
Levorphanol—Rash—Conjugated Estrogens—prostate cancer	6.48e-05	0.00117	CcSEcCtD
Levorphanol—Dermatitis—Conjugated Estrogens—prostate cancer	6.47e-05	0.00116	CcSEcCtD
Levorphanol—Arrhythmia—Capecitabine—prostate cancer	6.45e-05	0.00116	CcSEcCtD
Levorphanol—Confusional state—Etoposide—prostate cancer	6.43e-05	0.00116	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—prostate cancer	6.4e-05	0.00115	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—prostate cancer	6.37e-05	0.00115	CcSEcCtD
Levorphanol—Feeling abnormal—Mitoxantrone—prostate cancer	6.32e-05	0.00114	CcSEcCtD
Levorphanol—Gastrointestinal pain—Mitoxantrone—prostate cancer	6.27e-05	0.00113	CcSEcCtD
Levorphanol—Muscle spasms—Docetaxel—prostate cancer	6.24e-05	0.00112	CcSEcCtD
Levorphanol—Estrone—CYP3A5—prostate cancer	6.22e-05	0.0261	CrCbGaD
Levorphanol—Tachycardia—Etoposide—prostate cancer	6.22e-05	0.00112	CcSEcCtD
Levorphanol—Dihydrocodeine—CYP3A4—prostate cancer	6.19e-05	0.0259	CrCbGaD
Levorphanol—Nausea—Goserelin—prostate cancer	6.16e-05	0.00111	CcSEcCtD
Levorphanol—Hyperhidrosis—Etoposide—prostate cancer	6.16e-05	0.00111	CcSEcCtD
Levorphanol—Nausea—Conjugated Estrogens—prostate cancer	6.1e-05	0.0011	CcSEcCtD
Levorphanol—Urticaria—Mitoxantrone—prostate cancer	6.09e-05	0.0011	CcSEcCtD
Levorphanol—Abdominal pain—Mitoxantrone—prostate cancer	6.06e-05	0.00109	CcSEcCtD
Levorphanol—Muscle spasms—Capecitabine—prostate cancer	6.04e-05	0.00109	CcSEcCtD
Levorphanol—Flushing—Prednisone—prostate cancer	5.97e-05	0.00107	CcSEcCtD
Levorphanol—Hypotension—Etoposide—prostate cancer	5.96e-05	0.00107	CcSEcCtD
Levorphanol—Estradiol—CYP1B1—prostate cancer	5.92e-05	0.0248	CrCbGaD
Levorphanol—Estradiol—SHBG—prostate cancer	5.92e-05	0.0248	CrCbGaD
Levorphanol—Dysuria—Epirubicin—prostate cancer	5.88e-05	0.00106	CcSEcCtD
Levorphanol—Estradiol—SLC22A1—prostate cancer	5.84e-05	0.0245	CrCbGaD
Levorphanol—Pruritus—Estradiol—prostate cancer	5.82e-05	0.00105	CcSEcCtD
Levorphanol—Arrhythmia—Prednisone—prostate cancer	5.74e-05	0.00103	CcSEcCtD
Levorphanol—Palpitations—Docetaxel—prostate cancer	5.74e-05	0.00103	CcSEcCtD
Levorphanol—Convulsion—Docetaxel—prostate cancer	5.62e-05	0.00101	CcSEcCtD
Levorphanol—Palpitations—Capecitabine—prostate cancer	5.55e-05	0.000999	CcSEcCtD
Levorphanol—Renal failure—Epirubicin—prostate cancer	5.51e-05	0.000991	CcSEcCtD
Levorphanol—Constipation—Etoposide—prostate cancer	5.45e-05	0.000981	CcSEcCtD
Levorphanol—Dizziness—Estradiol—prostate cancer	5.44e-05	0.000979	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—prostate cancer	5.44e-05	0.000978	CcSEcCtD
Levorphanol—Dry mouth—Docetaxel—prostate cancer	5.4e-05	0.000972	CcSEcCtD
Levorphanol—Sweating—Epirubicin—prostate cancer	5.37e-05	0.000966	CcSEcCtD
Levorphanol—Confusional state—Docetaxel—prostate cancer	5.34e-05	0.000961	CcSEcCtD
Levorphanol—Estrone—ESR1—prostate cancer	5.28e-05	0.0221	CrCbGaD
Levorphanol—Feeling abnormal—Etoposide—prostate cancer	5.25e-05	0.000945	CcSEcCtD
Levorphanol—Dry mouth—Capecitabine—prostate cancer	5.23e-05	0.000942	CcSEcCtD
Levorphanol—Vomiting—Estradiol—prostate cancer	5.23e-05	0.000941	CcSEcCtD
Levorphanol—Gastrointestinal pain—Etoposide—prostate cancer	5.21e-05	0.000938	CcSEcCtD
Levorphanol—Shock—Docetaxel—prostate cancer	5.21e-05	0.000938	CcSEcCtD
Levorphanol—Estradiol—AR—prostate cancer	5.19e-05	0.0217	CrCbGaD
Levorphanol—Rash—Estradiol—prostate cancer	5.19e-05	0.000933	CcSEcCtD
Levorphanol—Dermatitis—Estradiol—prostate cancer	5.18e-05	0.000932	CcSEcCtD
Levorphanol—Confusional state—Capecitabine—prostate cancer	5.17e-05	0.000931	CcSEcCtD
Levorphanol—Tachycardia—Docetaxel—prostate cancer	5.17e-05	0.00093	CcSEcCtD
Levorphanol—Agitation—Prednisone—prostate cancer	5.14e-05	0.000926	CcSEcCtD
Levorphanol—Bradycardia—Epirubicin—prostate cancer	5.12e-05	0.000921	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—prostate cancer	5.1e-05	0.000917	CcSEcCtD
Levorphanol—Urticaria—Etoposide—prostate cancer	5.06e-05	0.000911	CcSEcCtD
Levorphanol—Shock—Capecitabine—prostate cancer	5.05e-05	0.000908	CcSEcCtD
Levorphanol—Abdominal pain—Etoposide—prostate cancer	5.04e-05	0.000907	CcSEcCtD
Levorphanol—Tachycardia—Capecitabine—prostate cancer	5.01e-05	0.000901	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—prostate cancer	4.97e-05	0.000894	CcSEcCtD
Levorphanol—Hyperhidrosis—Capecitabine—prostate cancer	4.96e-05	0.000892	CcSEcCtD
Levorphanol—Hypotension—Docetaxel—prostate cancer	4.95e-05	0.000891	CcSEcCtD
Levorphanol—Nausea—Estradiol—prostate cancer	4.89e-05	0.000879	CcSEcCtD
Levorphanol—Vomiting—Mitoxantrone—prostate cancer	4.87e-05	0.000877	CcSEcCtD
Levorphanol—Convulsion—Prednisone—prostate cancer	4.85e-05	0.000873	CcSEcCtD
Levorphanol—Visual impairment—Epirubicin—prostate cancer	4.85e-05	0.000872	CcSEcCtD
Levorphanol—Rash—Mitoxantrone—prostate cancer	4.83e-05	0.000869	CcSEcCtD
Levorphanol—Dermatitis—Mitoxantrone—prostate cancer	4.83e-05	0.000869	CcSEcCtD
Levorphanol—Hypotension—Capecitabine—prostate cancer	4.79e-05	0.000862	CcSEcCtD
Levorphanol—Insomnia—Docetaxel—prostate cancer	4.79e-05	0.000862	CcSEcCtD
Levorphanol—Hydrocodone—CYP3A4—prostate cancer	4.74e-05	0.0199	CrCbGaD
Levorphanol—Bradycardia—Doxorubicin—prostate cancer	4.74e-05	0.000852	CcSEcCtD
Levorphanol—Estradiol—CYP3A5—prostate cancer	4.72e-05	0.0198	CrCbGaD
Levorphanol—Flushing—Epirubicin—prostate cancer	4.67e-05	0.00084	CcSEcCtD
Levorphanol—Dyspepsia—Docetaxel—prostate cancer	4.66e-05	0.000839	CcSEcCtD
Levorphanol—Insomnia—Capecitabine—prostate cancer	4.64e-05	0.000835	CcSEcCtD
Levorphanol—Nausea—Mitoxantrone—prostate cancer	4.55e-05	0.000819	CcSEcCtD
Levorphanol—Constipation—Docetaxel—prostate cancer	4.53e-05	0.000815	CcSEcCtD
Levorphanol—Dyspepsia—Capecitabine—prostate cancer	4.51e-05	0.000812	CcSEcCtD
Levorphanol—Pruritus—Etoposide—prostate cancer	4.51e-05	0.000811	CcSEcCtD
Levorphanol—Shock—Prednisone—prostate cancer	4.49e-05	0.000809	CcSEcCtD
Levorphanol—Arrhythmia—Epirubicin—prostate cancer	4.49e-05	0.000808	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—prostate cancer	4.48e-05	0.000807	CcSEcCtD
Levorphanol—Tachycardia—Prednisone—prostate cancer	4.46e-05	0.000802	CcSEcCtD
Levorphanol—Dextromethorphan—CYP2E1—prostate cancer	4.46e-05	0.0187	CrCbGaD
Levorphanol—Hyperhidrosis—Prednisone—prostate cancer	4.42e-05	0.000795	CcSEcCtD
Levorphanol—Dextromethorphan—CYP2C19—prostate cancer	4.41e-05	0.0185	CrCbGaD
Levorphanol—Constipation—Capecitabine—prostate cancer	4.39e-05	0.000789	CcSEcCtD
Levorphanol—Feeling abnormal—Docetaxel—prostate cancer	4.37e-05	0.000786	CcSEcCtD
Levorphanol—Gastrointestinal pain—Docetaxel—prostate cancer	4.33e-05	0.000779	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—prostate cancer	4.32e-05	0.000777	CcSEcCtD
Levorphanol—Tension—Epirubicin—prostate cancer	4.3e-05	0.000773	CcSEcCtD
Levorphanol—Estrone—CYP2E1—prostate cancer	4.28e-05	0.0179	CrCbGaD
Levorphanol—Nervousness—Epirubicin—prostate cancer	4.25e-05	0.000765	CcSEcCtD
Levorphanol—Feeling abnormal—Capecitabine—prostate cancer	4.23e-05	0.000761	CcSEcCtD
Levorphanol—Estrone—CYP1A1—prostate cancer	4.22e-05	0.0177	CrCbGaD
Levorphanol—Dizziness—Etoposide—prostate cancer	4.22e-05	0.000758	CcSEcCtD
Levorphanol—Muscle spasms—Epirubicin—prostate cancer	4.21e-05	0.000757	CcSEcCtD
Levorphanol—Gastrointestinal pain—Capecitabine—prostate cancer	4.19e-05	0.000755	CcSEcCtD
Levorphanol—Abdominal pain—Docetaxel—prostate cancer	4.19e-05	0.000754	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—prostate cancer	4.16e-05	0.000748	CcSEcCtD
Levorphanol—Insomnia—Prednisone—prostate cancer	4.13e-05	0.000744	CcSEcCtD
Levorphanol—Urticaria—Capecitabine—prostate cancer	4.07e-05	0.000733	CcSEcCtD
Levorphanol—Abdominal pain—Capecitabine—prostate cancer	4.05e-05	0.00073	CcSEcCtD
Levorphanol—Vomiting—Etoposide—prostate cancer	4.05e-05	0.000729	CcSEcCtD
Levorphanol—Agitation—Epirubicin—prostate cancer	4.02e-05	0.000724	CcSEcCtD
Levorphanol—Dyspepsia—Prednisone—prostate cancer	4.02e-05	0.000724	CcSEcCtD
Levorphanol—Rash—Etoposide—prostate cancer	4.02e-05	0.000723	CcSEcCtD
Levorphanol—Dermatitis—Etoposide—prostate cancer	4.02e-05	0.000723	CcSEcCtD
Levorphanol—Estradiol—ESR1—prostate cancer	4e-05	0.0168	CrCbGaD
Levorphanol—Tension—Doxorubicin—prostate cancer	3.98e-05	0.000715	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—prostate cancer	3.93e-05	0.000708	CcSEcCtD
Levorphanol—Hydromorphone—CYP3A4—prostate cancer	3.93e-05	0.0165	CrCbGaD
Levorphanol—Constipation—Prednisone—prostate cancer	3.91e-05	0.000703	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—prostate cancer	3.89e-05	0.000701	CcSEcCtD
Levorphanol—Palpitations—Epirubicin—prostate cancer	3.87e-05	0.000696	CcSEcCtD
Levorphanol—Convulsion—Epirubicin—prostate cancer	3.79e-05	0.000683	CcSEcCtD
Levorphanol—Nausea—Etoposide—prostate cancer	3.79e-05	0.000681	CcSEcCtD
Levorphanol—Feeling abnormal—Prednisone—prostate cancer	3.76e-05	0.000677	CcSEcCtD
Levorphanol—Pruritus—Docetaxel—prostate cancer	3.75e-05	0.000674	CcSEcCtD
Levorphanol—Gastrointestinal pain—Prednisone—prostate cancer	3.74e-05	0.000672	CcSEcCtD
Levorphanol—Agitation—Doxorubicin—prostate cancer	3.72e-05	0.00067	CcSEcCtD
Levorphanol—Dry mouth—Epirubicin—prostate cancer	3.65e-05	0.000656	CcSEcCtD
Levorphanol—Urticaria—Prednisone—prostate cancer	3.63e-05	0.000653	CcSEcCtD
Levorphanol—Pruritus—Capecitabine—prostate cancer	3.63e-05	0.000653	CcSEcCtD
Levorphanol—Abdominal pain—Prednisone—prostate cancer	3.61e-05	0.00065	CcSEcCtD
Levorphanol—Confusional state—Epirubicin—prostate cancer	3.6e-05	0.000648	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—prostate cancer	3.58e-05	0.000644	CcSEcCtD
Levorphanol—Shock—Epirubicin—prostate cancer	3.52e-05	0.000633	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—prostate cancer	3.51e-05	0.000632	CcSEcCtD
Levorphanol—Dizziness—Docetaxel—prostate cancer	3.5e-05	0.00063	CcSEcCtD
Levorphanol—Tachycardia—Epirubicin—prostate cancer	3.49e-05	0.000627	CcSEcCtD
Levorphanol—Hyperhidrosis—Epirubicin—prostate cancer	3.45e-05	0.000622	CcSEcCtD
Levorphanol—Dizziness—Capecitabine—prostate cancer	3.39e-05	0.00061	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—prostate cancer	3.37e-05	0.000607	CcSEcCtD
Levorphanol—Vomiting—Docetaxel—prostate cancer	3.37e-05	0.000606	CcSEcCtD
Levorphanol—Morphine—CYP3A4—prostate cancer	3.34e-05	0.014	CrCbGaD
Levorphanol—Rash—Docetaxel—prostate cancer	3.34e-05	0.000601	CcSEcCtD
Levorphanol—Hypotension—Epirubicin—prostate cancer	3.34e-05	0.000601	CcSEcCtD
Levorphanol—Dermatitis—Docetaxel—prostate cancer	3.34e-05	0.0006	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—prostate cancer	3.33e-05	0.0006	CcSEcCtD
Levorphanol—Vomiting—Capecitabine—prostate cancer	3.26e-05	0.000587	CcSEcCtD
Levorphanol—Shock—Doxorubicin—prostate cancer	3.25e-05	0.000585	CcSEcCtD
Levorphanol—Rash—Capecitabine—prostate cancer	3.23e-05	0.000582	CcSEcCtD
Levorphanol—Pruritus—Prednisone—prostate cancer	3.23e-05	0.000582	CcSEcCtD
Levorphanol—Insomnia—Epirubicin—prostate cancer	3.23e-05	0.000582	CcSEcCtD
Levorphanol—Dermatitis—Capecitabine—prostate cancer	3.23e-05	0.000581	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—prostate cancer	3.23e-05	0.000581	CcSEcCtD
Levorphanol—Estradiol—CYP2C19—prostate cancer	3.21e-05	0.0134	CrCbGaD
Levorphanol—Estradiol—CYP1A1—prostate cancer	3.2e-05	0.0134	CrCbGaD
Levorphanol—Hyperhidrosis—Doxorubicin—prostate cancer	3.2e-05	0.000575	CcSEcCtD
Levorphanol—Nausea—Docetaxel—prostate cancer	3.15e-05	0.000566	CcSEcCtD
Levorphanol—Dyspepsia—Epirubicin—prostate cancer	3.15e-05	0.000566	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—prostate cancer	3.09e-05	0.000556	CcSEcCtD
Levorphanol—Constipation—Epirubicin—prostate cancer	3.06e-05	0.00055	CcSEcCtD
Levorphanol—Nausea—Capecitabine—prostate cancer	3.05e-05	0.000548	CcSEcCtD
Levorphanol—Dizziness—Prednisone—prostate cancer	3.02e-05	0.000544	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—prostate cancer	2.99e-05	0.000538	CcSEcCtD
Levorphanol—Feeling abnormal—Epirubicin—prostate cancer	2.94e-05	0.00053	CcSEcCtD
Levorphanol—Gastrointestinal pain—Epirubicin—prostate cancer	2.92e-05	0.000526	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—prostate cancer	2.91e-05	0.000524	CcSEcCtD
Levorphanol—Vomiting—Prednisone—prostate cancer	2.9e-05	0.000523	CcSEcCtD
Levorphanol—Rash—Prednisone—prostate cancer	2.88e-05	0.000518	CcSEcCtD
Levorphanol—Dermatitis—Prednisone—prostate cancer	2.88e-05	0.000518	CcSEcCtD
Levorphanol—Urticaria—Epirubicin—prostate cancer	2.84e-05	0.000511	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—prostate cancer	2.83e-05	0.000509	CcSEcCtD
Levorphanol—Abdominal pain—Epirubicin—prostate cancer	2.82e-05	0.000508	CcSEcCtD
Levorphanol—Dextromethorphan—CYP3A4—prostate cancer	2.81e-05	0.0118	CrCbGaD
Levorphanol—Feeling abnormal—Doxorubicin—prostate cancer	2.72e-05	0.00049	CcSEcCtD
Levorphanol—Nausea—Prednisone—prostate cancer	2.71e-05	0.000488	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—prostate cancer	2.7e-05	0.000486	CcSEcCtD
Levorphanol—Estrone—CYP3A4—prostate cancer	2.69e-05	0.0113	CrCbGaD
Levorphanol—Urticaria—Doxorubicin—prostate cancer	2.63e-05	0.000473	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—prostate cancer	2.61e-05	0.00047	CcSEcCtD
Levorphanol—Pruritus—Epirubicin—prostate cancer	2.53e-05	0.000455	CcSEcCtD
Levorphanol—Dizziness—Epirubicin—prostate cancer	2.36e-05	0.000425	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—prostate cancer	2.34e-05	0.000421	CcSEcCtD
Levorphanol—Vomiting—Epirubicin—prostate cancer	2.27e-05	0.000409	CcSEcCtD
Levorphanol—Rash—Epirubicin—prostate cancer	2.25e-05	0.000405	CcSEcCtD
Levorphanol—Dermatitis—Epirubicin—prostate cancer	2.25e-05	0.000405	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—prostate cancer	2.19e-05	0.000393	CcSEcCtD
Levorphanol—Nausea—Epirubicin—prostate cancer	2.12e-05	0.000382	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—prostate cancer	2.1e-05	0.000378	CcSEcCtD
Levorphanol—Rash—Doxorubicin—prostate cancer	2.08e-05	0.000375	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—prostate cancer	2.08e-05	0.000375	CcSEcCtD
Levorphanol—Estradiol—CYP3A4—prostate cancer	2.04e-05	0.00855	CrCbGaD
Levorphanol—Nausea—Doxorubicin—prostate cancer	1.96e-05	0.000353	CcSEcCtD
Levorphanol—OPRD1—Signaling Pathways—NGFR—prostate cancer	6.14e-06	0.000443	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGFR4—prostate cancer	6.12e-06	0.000442	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PARP1—prostate cancer	6.12e-06	0.000442	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAP3K7—prostate cancer	6.07e-06	0.000438	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CALCA—prostate cancer	6.04e-06	0.000436	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL12—prostate cancer	5.9e-06	0.000426	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGF10—prostate cancer	5.84e-06	0.000421	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFBR1—prostate cancer	5.8e-06	0.000419	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTHLH—prostate cancer	5.8e-06	0.000419	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ADRB2—prostate cancer	5.78e-06	0.000417	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKR1C3—prostate cancer	5.71e-06	0.000412	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—JAK2—prostate cancer	5.7e-06	0.000411	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKACB—prostate cancer	5.68e-06	0.00041	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MAP2K1—prostate cancer	5.68e-06	0.00041	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CD—prostate cancer	5.64e-06	0.000407	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VAV3—prostate cancer	5.63e-06	0.000407	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CG—prostate cancer	5.62e-06	0.000406	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CASP9—prostate cancer	5.56e-06	0.000401	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TGFBR2—prostate cancer	5.55e-06	0.000401	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—THBS1—prostate cancer	5.54e-06	0.0004	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PPP3CA—prostate cancer	5.54e-06	0.0004	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ITPR1—prostate cancer	5.46e-06	0.000394	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ANXA1—prostate cancer	5.46e-06	0.000394	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CD—prostate cancer	5.44e-06	0.000393	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CB—prostate cancer	5.41e-06	0.000391	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PRKCQ—prostate cancer	5.39e-06	0.000389	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NGFR—prostate cancer	5.39e-06	0.000389	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKCZ—prostate cancer	5.35e-06	0.000386	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAP3K7—prostate cancer	5.32e-06	0.000384	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CG—prostate cancer	5.23e-06	0.000378	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF1R—prostate cancer	5.22e-06	0.000377	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCL8—prostate cancer	5.2e-06	0.000375	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—JAK2—prostate cancer	5.17e-06	0.000373	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PARP1—prostate cancer	5.17e-06	0.000373	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGFR4—prostate cancer	5.17e-06	0.000373	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGF10—prostate cancer	5.12e-06	0.000369	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CALCA—prostate cancer	5.11e-06	0.000369	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ADRB2—prostate cancer	5.07e-06	0.000366	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LPL—prostate cancer	5.01e-06	0.000361	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—JAK2—prostate cancer	5e-06	0.000361	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL12—prostate cancer	4.99e-06	0.00036	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAP2K1—prostate cancer	4.98e-06	0.000359	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—IL2—prostate cancer	4.97e-06	0.000359	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PDGFRB—prostate cancer	4.96e-06	0.000358	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CD—prostate cancer	4.94e-06	0.000357	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VAV3—prostate cancer	4.94e-06	0.000356	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CB—prostate cancer	4.91e-06	0.000355	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFBR2—prostate cancer	4.87e-06	0.000351	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ITGB3—prostate cancer	4.84e-06	0.000349	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ITPR1—prostate cancer	4.79e-06	0.000346	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CG—prostate cancer	4.75e-06	0.000343	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CB—prostate cancer	4.75e-06	0.000342	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL8—prostate cancer	4.72e-06	0.000341	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASP9—prostate cancer	4.7e-06	0.000339	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ERBB3—prostate cancer	4.69e-06	0.000339	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGFR2—prostate cancer	4.68e-06	0.000338	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CD—prostate cancer	4.6e-06	0.000332	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF1R—prostate cancer	4.58e-06	0.000331	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL8—prostate cancer	4.56e-06	0.000329	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKCQ—prostate cancer	4.55e-06	0.000329	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NGFR—prostate cancer	4.55e-06	0.000329	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—JAK2—prostate cancer	4.54e-06	0.000327	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL2—prostate cancer	4.51e-06	0.000326	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAP3K7—prostate cancer	4.5e-06	0.000325	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TERT—prostate cancer	4.5e-06	0.000325	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LPL—prostate cancer	4.39e-06	0.000317	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—IL2—prostate cancer	4.36e-06	0.000315	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PDGFRB—prostate cancer	4.35e-06	0.000314	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGF10—prostate cancer	4.33e-06	0.000312	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CB—prostate cancer	4.31e-06	0.000311	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HIF1A—prostate cancer	4.3e-06	0.00031	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADRB2—prostate cancer	4.28e-06	0.000309	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ITGB3—prostate cancer	4.24e-06	0.000306	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—JAK2—prostate cancer	4.22e-06	0.000305	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAP2K1—prostate cancer	4.21e-06	0.000304	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LEP—prostate cancer	4.2e-06	0.000303	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CD—prostate cancer	4.18e-06	0.000302	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VAV3—prostate cancer	4.17e-06	0.000301	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CAV1—prostate cancer	4.16e-06	0.0003	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL8—prostate cancer	4.14e-06	0.000299	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFBR2—prostate cancer	4.11e-06	0.000297	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ERBB3—prostate cancer	4.11e-06	0.000297	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KDR—prostate cancer	4.11e-06	0.000297	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGFR2—prostate cancer	4.11e-06	0.000296	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ITPR1—prostate cancer	4.05e-06	0.000292	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CB—prostate cancer	4.01e-06	0.000289	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ESR1—prostate cancer	4.01e-06	0.000289	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL2—prostate cancer	3.96e-06	0.000286	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TERT—prostate cancer	3.94e-06	0.000285	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—BAD—prostate cancer	3.91e-06	0.000282	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF1R—prostate cancer	3.87e-06	0.000279	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL8—prostate cancer	3.85e-06	0.000278	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—JAK2—prostate cancer	3.83e-06	0.000277	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APC—prostate cancer	3.79e-06	0.000273	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CG—prostate cancer	3.79e-06	0.000273	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HIF1A—prostate cancer	3.77e-06	0.000272	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IRS1—prostate cancer	3.75e-06	0.00027	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGF—prostate cancer	3.75e-06	0.00027	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LPL—prostate cancer	3.71e-06	0.000268	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—IL2—prostate cancer	3.68e-06	0.000266	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LEP—prostate cancer	3.68e-06	0.000266	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PDGFRB—prostate cancer	3.68e-06	0.000265	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CAV1—prostate cancer	3.65e-06	0.000263	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CB—prostate cancer	3.64e-06	0.000263	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GSK3B—prostate cancer	3.64e-06	0.000262	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KDR—prostate cancer	3.61e-06	0.00026	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—INS—prostate cancer	3.59e-06	0.000259	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ITGB3—prostate cancer	3.58e-06	0.000259	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ESR1—prostate cancer	3.51e-06	0.000254	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CREBBP—prostate cancer	3.51e-06	0.000254	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL8—prostate cancer	3.5e-06	0.000253	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ERBB3—prostate cancer	3.48e-06	0.000251	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGFR2—prostate cancer	3.47e-06	0.000251	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF1—prostate cancer	3.47e-06	0.00025	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—EGFR—prostate cancer	3.45e-06	0.000249	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—BAD—prostate cancer	3.43e-06	0.000248	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAP2K1—prostate cancer	3.35e-06	0.000242	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL2—prostate cancer	3.34e-06	0.000241	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TERT—prostate cancer	3.33e-06	0.000241	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CD—prostate cancer	3.33e-06	0.00024	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CG—prostate cancer	3.32e-06	0.00024	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APC—prostate cancer	3.32e-06	0.00024	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CA—prostate cancer	3.3e-06	0.000238	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SERPINE1—prostate cancer	3.29e-06	0.000238	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGF—prostate cancer	3.28e-06	0.000237	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IRS1—prostate cancer	3.28e-06	0.000237	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—KRAS—prostate cancer	3.26e-06	0.000235	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGF2—prostate cancer	3.19e-06	0.00023	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GSK3B—prostate cancer	3.19e-06	0.00023	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HIF1A—prostate cancer	3.19e-06	0.00023	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOS3—prostate cancer	3.15e-06	0.000227	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—INS—prostate cancer	3.14e-06	0.000227	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LEP—prostate cancer	3.11e-06	0.000225	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CAV1—prostate cancer	3.08e-06	0.000222	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CREBBP—prostate cancer	3.08e-06	0.000222	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JAK2—prostate cancer	3.06e-06	0.000221	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KDR—prostate cancer	3.05e-06	0.00022	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF1—prostate cancer	3.04e-06	0.00022	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—EGFR—prostate cancer	3.03e-06	0.000218	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CA—prostate cancer	3e-06	0.000216	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MDM2—prostate cancer	2.98e-06	0.000215	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ESR1—prostate cancer	2.97e-06	0.000214	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ERBB2—prostate cancer	2.94e-06	0.000212	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAP2K1—prostate cancer	2.94e-06	0.000212	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CD—prostate cancer	2.92e-06	0.000211	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CB—prostate cancer	2.9e-06	0.00021	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—BAD—prostate cancer	2.9e-06	0.000209	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CA—prostate cancer	2.89e-06	0.000209	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SERPINE1—prostate cancer	2.89e-06	0.000208	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—KRAS—prostate cancer	2.86e-06	0.000206	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APC—prostate cancer	2.81e-06	0.000203	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CG—prostate cancer	2.81e-06	0.000203	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGF2—prostate cancer	2.8e-06	0.000202	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL8—prostate cancer	2.79e-06	0.000201	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGF—prostate cancer	2.78e-06	0.0002	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IRS1—prostate cancer	2.78e-06	0.0002	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOS3—prostate cancer	2.76e-06	0.000199	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN1B—prostate cancer	2.72e-06	0.000197	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT1—prostate cancer	2.7e-06	0.000195	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GSK3B—prostate cancer	2.69e-06	0.000194	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JAK2—prostate cancer	2.68e-06	0.000193	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CASP3—prostate cancer	2.67e-06	0.000193	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL2—prostate cancer	2.67e-06	0.000192	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—INS—prostate cancer	2.66e-06	0.000192	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6—prostate cancer	2.65e-06	0.000191	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CA—prostate cancer	2.63e-06	0.00019	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MDM2—prostate cancer	2.62e-06	0.000189	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CREBBP—prostate cancer	2.6e-06	0.000188	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCND1—prostate cancer	2.6e-06	0.000188	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ERBB2—prostate cancer	2.58e-06	0.000186	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CTNNB1—prostate cancer	2.57e-06	0.000186	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF1—prostate cancer	2.57e-06	0.000186	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—EGFR—prostate cancer	2.56e-06	0.000185	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CB—prostate cancer	2.55e-06	0.000184	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP9—prostate cancer	2.52e-06	0.000182	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN1A—prostate cancer	2.51e-06	0.000181	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTEN—prostate cancer	2.51e-06	0.000181	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	2.48e-06	0.000179	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	2.47e-06	0.000178	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT1—prostate cancer	2.45e-06	0.000177	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL8—prostate cancer	2.45e-06	0.000177	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	2.44e-06	0.000176	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	2.44e-06	0.000176	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—KRAS—prostate cancer	2.42e-06	0.000174	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EP300—prostate cancer	2.39e-06	0.000173	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	2.39e-06	0.000172	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGF2—prostate cancer	2.36e-06	0.000171	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	2.36e-06	0.000171	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CASP3—prostate cancer	2.34e-06	0.000169	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL2—prostate cancer	2.34e-06	0.000169	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOS3—prostate cancer	2.33e-06	0.000168	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SRC—prostate cancer	2.33e-06	0.000168	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6—prostate cancer	2.33e-06	0.000168	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCND1—prostate cancer	2.28e-06	0.000164	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VEGFA—prostate cancer	2.27e-06	0.000164	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JAK2—prostate cancer	2.27e-06	0.000163	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	2.26e-06	0.000163	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STAT3—prostate cancer	2.24e-06	0.000162	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	2.22e-06	0.00016	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP9—prostate cancer	2.21e-06	0.00016	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MDM2—prostate cancer	2.21e-06	0.00016	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	2.2e-06	0.000159	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTEN—prostate cancer	2.2e-06	0.000159	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ERBB2—prostate cancer	2.18e-06	0.000157	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	2.15e-06	0.000155	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT1—prostate cancer	2.15e-06	0.000155	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EP300—prostate cancer	2.1e-06	0.000151	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MYC—prostate cancer	2.08e-06	0.00015	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TGFB1—prostate cancer	2.08e-06	0.00015	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL8—prostate cancer	2.07e-06	0.000149	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SRC—prostate cancer	2.04e-06	0.000147	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGFR—prostate cancer	2.04e-06	0.000147	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	2.02e-06	0.000146	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	2e-06	0.000144	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VEGFA—prostate cancer	1.99e-06	0.000143	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASP3—prostate cancer	1.98e-06	0.000143	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL2—prostate cancer	1.98e-06	0.000143	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT3—prostate cancer	1.97e-06	0.000142	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6—prostate cancer	1.97e-06	0.000142	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KRAS—prostate cancer	1.93e-06	0.000139	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCND1—prostate cancer	1.93e-06	0.000139	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	1.91e-06	0.000138	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP9—prostate cancer	1.87e-06	0.000135	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	1.86e-06	0.000134	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTEN—prostate cancer	1.86e-06	0.000134	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MYC—prostate cancer	1.83e-06	0.000132	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFB1—prostate cancer	1.82e-06	0.000132	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT1—prostate cancer	1.81e-06	0.000131	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGFR—prostate cancer	1.79e-06	0.000129	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EP300—prostate cancer	1.77e-06	0.000128	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	1.77e-06	0.000128	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SRC—prostate cancer	1.72e-06	0.000124	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TP53—prostate cancer	1.71e-06	0.000124	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KRAS—prostate cancer	1.69e-06	0.000122	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VEGFA—prostate cancer	1.68e-06	0.000121	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT3—prostate cancer	1.66e-06	0.00012	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6—prostate cancer	1.57e-06	0.000113	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	1.55e-06	0.000112	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MYC—prostate cancer	1.55e-06	0.000112	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFB1—prostate cancer	1.54e-06	0.000111	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGFR—prostate cancer	1.51e-06	0.000109	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TP53—prostate cancer	1.5e-06	0.000108	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT1—prostate cancer	1.45e-06	0.000104	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KRAS—prostate cancer	1.43e-06	0.000103	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6—prostate cancer	1.37e-06	9.92e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	1.31e-06	9.47e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TP53—prostate cancer	1.27e-06	9.16e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT1—prostate cancer	1.27e-06	9.15e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6—prostate cancer	1.16e-06	8.38e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT1—prostate cancer	1.07e-06	7.73e-05	CbGpPWpGaD
